"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to PHGE. [ FAQ on what and how to ask] For non-PHGE questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Jonathan Eitan Solomon MBA
Headquarter: 22 Einstein Street, Floor 4, Ness Ziona, Israel, 7414003
Industry: Biotechnology, Employees: 52
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. The company was founded in 2015 and is headquartered in Ness Ziona, Israel.
My Watchlist
